Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired motor activity in a CRISPR SCA5 L253P knock-in mouse is associated with selective β-III-spectrin subcellular redistribution in the cerebellum.

bioRxiv : the preprint server for biology·2026
Same author

Neural basis for mutant ATAXIN-1 induced respiratory dysfunction in mouse models of spinocerebellar ataxia type 1.

Neurobiology of disease·2026
Same author

Repeat-associated non-AUG translation as a common mechanism for the polyGln ataxias.

Cell reports·2025
Same author

Striatal pathology in Spinocerebellar Ataxia Type 1 mice: A comparative study with Huntington's disease.

bioRxiv : the preprint server for biology·2025
Same author

An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model.

Research square·2025
Same author

An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model.

Journal of neuroinflammation·2025

Related Experiment Video

Updated: May 25, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

Polyglutamine neurodegeneration: expanded glutamines enhance native functions.

Harry T Orr1

  • 1Institute for Translational Neuroscience, Department of laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USA. orrxx002@umn.edu

Current Opinion in Genetics & Development
|January 31, 2012
PubMed
Summary

Polyglutamine (polyQ) diseases result from expanded CAG repeats, leading to neurodegeneration. Evidence suggests toxicity may arise from an amplified native protein function, not a new one.

More Related Videos

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

LERLIC-MS/MS for In-depth Characterization and Quantification of Glutamine and Asparagine Deamidation in Shotgun Proteomics
08:01

LERLIC-MS/MS for In-depth Characterization and Quantification of Glutamine and Asparagine Deamidation in Shotgun Proteomics

Published on: April 9, 2017

Related Experiment Videos

Last Updated: May 25, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
09:06

Growth Assays to Assess Polyglutamine Toxicity in Yeast

Published on: March 5, 2012

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

LERLIC-MS/MS for In-depth Characterization and Quantification of Glutamine and Asparagine Deamidation in Shotgun Proteomics
08:01

LERLIC-MS/MS for In-depth Characterization and Quantification of Glutamine and Asparagine Deamidation in Shotgun Proteomics

Published on: April 9, 2017

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Nine neurodegenerative disorders are linked to expanded CAG trinucleotide repeats within gene coding regions, known as polyglutamine (polyQ) diseases.
  • A gain-of-function mechanism is implicated in polyQ disease pathogenesis.
  • The precise nature of this gain-of-function, whether it involves native or novel protein functions, remains debated.

Purpose of the Study:

  • To investigate the role of native versus novel protein functions in the toxicity associated with polyglutamine diseases.
  • To clarify the gain-of-function mechanism in polyQ disease pathogenesis.

Main Methods:

  • Analysis of genetic mutations causing polyglutamine diseases.
  • Review of existing evidence on protein function in polyQ disease models.
  • Comparative study of native protein functions and polyQ-expanded protein functions.

Main Results:

  • Accumulating evidence indicates that for at least three polyQ diseases, pathology is driven by an exaggerated native function of the affected protein.
  • The gain-of-function toxicity may stem from an amplification of the protein's normal role.

Conclusions:

  • The pathogenesis of several polyglutamine diseases appears to involve an overactivation of the protein's inherent function.
  • Understanding this mechanism is crucial for developing targeted therapies for polyQ neurodegenerative disorders.